Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury

doi:10.12114/j.issn.1007-9572.2023.0056

Chinese General Practice ›› 2023, Vol. 26 ›› Issue (24): 3050-3060.DOI: 10.12114/j.issn.1007-9572.2023.0056

• Original Research • Previous Articles Next Articles

Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury

1. Department of Encephalopathy, the Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230061, China
2. The Second Clinical Medical College, Anhui University of Chinese Medicine, Hefei 230061, China
3. Department of TCM, Brain Hospital Affiliated to Guangzhou Medical University, Guangzhou 510370, China
4. Department of Geriatrics, the Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230061, China

Received:2022-12-20 Revised:2023-03-10 Published:2023-08-20 Online:2023-03-28
Contact: HAN Wei

"通督调神"电针预处理介导miR-124-3p/GSK-3β/Cyp-D信号通路对脑缺血再灌注损伤大鼠脑皮质线粒体通透性转换孔的影响及机制探讨

1．230061　安徽省合肥市，安徽中医药大学第二附属医院脑病科
2．230061　安徽省合肥市，安徽中医药大学第二临床医学院
3．510370　广东省广州市，广州医科大学附属脑科医院中医科
4．230061　安徽省合肥市，安徽中医药大学第二附属医院老年病科

通讯作者: 韩为
作者简介:
作者贡献：张国庆、童婷婷、李奎武提出研究构思与实验设计，负责实验实施，观察指标的测量与数据收集；张国庆负责撰写论文初稿；李奎武负责统计学分析；吴晓晴、汪俊丽负责数据收集与统计结果审核；童婷婷、张利达、张君宇负责整体实验评估，观察指标的数据收集；韩为、王颖负责文章的质量控制及审校，对文章整体进行监督管理；所有作者确认了论文终稿。
基金资助:
国家自然科学基金面上项目(81973933); 安徽省第十三批115产业创新团队"针药结合防治脑病创新团队"项目(皖人才办[2020]4号); 安徽省名中医王颖工作室建设项目(中发展[2022]5号)

Abstract

Abstract:

Background

The incidence, mortality and disability rates of ischemic stroke are high, and the reperfusion injury after thrombolytic therapy has a great impact on patients. Acupuncture is a characteristic therapy for the treatment of the disease, but the action mechanism remains unclear.

Objective

To observe the effect of Tongdu Tiaoshen electroacupuncture (EA) pretreatment on miR-124-3p/glycogen synthase kinase β (GSK-3β) /cyclin D (Cyp-D) signaling pathway and mitochondrial permeability transition pore (MPTP) of cerebral ischemia-reperfusion injury (CIRI) rats, and explore its possible mechanism of prevention and control of CIRI.

Methods

From June to August 2022, a total of 100 clean SD rats were randomly divided into the sham operation group, model group, EA group, agonist group and EA + inhibitor group, with 20 rats in each group. For 7 d of intervention before modeling, in the EA group and EA + inhibitor group, "Baihui" (GV 20) , "Fengfu" (GV 16) and "Dazhui" (GV 14) were selected to perform electroacupuncture 1 time a day for 7 days. For 24 h before modeling, miR-124 agonist and inhibitor (5 nmol) were injected into the lateral ventricles in the EA + agonist group and inhibitor group. Except for the sham operation group, the right cerebral ischemia-reperfusion model of rats was prepared by the modified suture method in the rest groups. The right cerebral cortex of rats was taken, the degree of neurological impairment in each group was observed using mNSS scale and TTC staining, the nerve cell injury was observed by TUNEL staining and transmission electron microscopy. The expressions of GSK-3β, p-GSK-3β, Cyp-D, Cyt-C and Caspase-3 in cerebral cortex of each group were detected by immunofluorescence staining, Western blot and real-time quantitative PCR. The degree of MPTP openness was detected by flow cytometry, the higher rate of MPTP-positive cells indicated greater degress of MPTP openness.

Results

Except for the sham operation group, all rest groups of rats were successfully modeled. Compared with the sham operation group, mNSS score and infarct volume of brain tissue were increased, mitochondrial structure was seriously damaged, cell apoptosis index was increased, p-GSK-3β positive expression was reduced, Cyp-D positive expression was enhanced, miR-124-3p, Cyp-D, Cyt-C and Caspase-3 mRNA expressions were increased, p-GSK-3β/ GSK-3β ratio was decreased, relative Cyp-D, Cyt-C, and Caspase-3 protein expressions were increased, and MPTP openness degree was increased in the model group (P<0.05) . Compared with the model group, mNSS score and relative infarct volume were decreased, mitochondrial structure destruction was relieved, p-GSK-3β/GSK-3β ratio was increased, and relative expression of Caspase-3 protein was decreased in the electroacupuncture group and inhibitor group; the mRNA expression of GSK-3βwas increased in electroacupuncture + agonist group (P<0.05) ; apoptosis index was decreased, positive expression of p-GSK-3β was reduced and positive expression of Cyp-D was enhanced respectively, miR-124-3p, Cyp-D, Cyt-C and Caspase-3 mRNA expressions were decreased, Cyp-D and Cyt-C protein expressions were decreased, the degree of MPTP openness was decreased in the electroacupuncture group, inhibitor group and electroacupuncture + agonist group (P<0.05) . Compared with the electroacupuncture group, p-GSK-3β positive expression was enhanced, Cyp-D positive expression was reduced, miR-124-3p and Cyp-D, Cyt-C, Caspase-3 mRNA expressions were decreased, GSK-3β mRNA expression was increased, Cyp-D and Cyt-C protein expressions were decreased, and MPTP openness degree was reduced in the agonist group (P<0.05) ; the apoptosis index was increased, the positive expression of P-GSK-3β was reduced, the positive expression of Cyp-D was enhanced, the expressions of miR-124-3p, Cyt-C and Caspase-3 mRNA were increased, the expressions of Cyp-D and Cyt-C protein were increased, and the openness degree of MPTP was increased in the electroacupuncture + agonist group (P<0.05) .

Conclusion

Tongdu Tiaoshen electroacupuncture pretreatment can alleviate neurological impairment in cerebral ischemia-reperfusion rats, the mechanism may be related to mediating miR-124-3p/GSK-3β/Cyp-D signaling pathway, inhibiting MPTP openness and thus reducing cell injury. The results of this study further verified the therapeutic effect of Tongdu Tiaoshen electroacupuncture in the treatment of CIRI from the mechanism, providing a new scientific basis for preventive treatment of disease of TCM and promote its clinical application.

Key words: Reperfusion injury, Brain ischemia, Stroke, Mitochondrial permeability transition pore, Tongdu Tiaoshen, Electroacupuncture therapy, miR-124-3p, Point GV20 (Baihui), Point GV16 (Fengfu), Point GV14 (Dazhui)

摘要：

背景

缺血性脑卒中发病率、死亡率、致残率均较高，溶栓后的再灌注损伤对患者影响较大，针刺是治疗本病的特色疗法，但作用机制尚不明确。

目的

探讨"通督调神"电针预处理对脑缺血再灌注损伤（CIRI）大鼠miR-124-3p/糖原合成酶激酶β（GSK-3β）/亲环素D（Cyp-D）信号通路及线粒体膜通透性转换孔（MPTP）的影响，探讨其防治CIRI的可能机制。

方法

2022年6—8月，将100只清洁级SD大鼠随机分为假手术组、模型组、电针组、抑制剂组和电针+激动剂组，每组20只。造模前干预7 d，电针组、电针+激动剂组选取通督调神穴组：百会、风府、大椎穴进行电针干预，1次/d，连续7 d；造模前24 h电针+激动剂组和抑制剂组分别侧脑室注射miR-124激动剂和抑制剂（5 nmol）。除假手术组，余组采用改良线栓法制备大鼠右侧脑缺血再灌注模型；造模成功后，取大鼠右侧脑皮质，采用改良神经功能损伤评分量表（mNSS）、TTC染色观察各组大鼠神经功能损伤程度，TUNEL染色以及透射电镜观察神经细胞损伤情况；免疫荧光染色、Western blotting、实时荧光定量PCR检测各组大鼠脑皮质GSK-3β、p-GSK-3β、Cyp-D、细胞色素C（Cyt-C）、半胱氨酸天冬氨酸蛋白酶3（Caspase-3）表达；流式细胞检测MPTP开放程度，MPTP阳性细胞率越高，代表MPTP开放程度越大。

结果

除假手术组，各组大鼠均造模成功。与假手术组比较，模型组大鼠mNSS评分及相对脑梗死体积均增加，线粒体结构破坏严重，细胞凋亡指数升高，p-GSK-3β、Cyp-D阳性表达分别减弱和增强，miR-124-3p及Cyp-D、Cyt-C、Caspase-3 mRNA表达增高，p-GSK-3β/ GSK-3β值降低，Cyp-D、Cyt-C、Caspase-3蛋白相对表达量增高，MPTP开放程度增加（P<0.05）。与模型组比较，电针组、抑制剂组mNSS评分及相对脑梗死体积均降低，线粒体结构破坏减轻，p-GSK-3β/GSK-3β增加，Caspase-3蛋白相对表达量降低；电针+激动剂组GSK-3β mRNA表达增高（P<0.05）；电针组、抑制剂组、电针+激动剂组细胞凋亡指数降低，p-GSK-3β、Cyp-D阳性表达分别减弱和增强，miR-124-3p及Cyp-D、Cyt-C、Caspase-3 mRNA表达降低，Cyp-D、Cyt-C蛋白相对表达量降低，MPTP开放程度降低（P<0.05）。与电针组比较，抑制剂组p-GSK-3β阳性表达增强，Cyp-D阳性表达减弱，miR-124-3p及Cyp-D、Cyt-C、Caspase-3 mRNA表达降低，GSK-3β mRNA表达增高，Cyp-D、Cyt-C蛋白相对表达量降低，MPTP开放程度降低（P<0.05）；电针+激动剂组细胞凋亡指数增高，p-GSK-3β阳性表达减弱，Cyp-D阳性表达增强，miR-124-3p、Cyt-C、Caspase-3 mRNA表达增高，Cyp-D、Cyt-C蛋白相对表达量增高，MPTP开放程度增加（P<0.05）。

结论

"通督调神"电针预处理可减轻CIRI大鼠神经损伤，其机制可能与介导miR-124-3p/GSK-3β/Cyp-D信号通路、抑制MPTP开放进而减轻细胞损伤相关。这一研究结果从机制上进一步验证了"通督调神"针法治疗CIRI的疗效，同时为中医"治未病"提供新的科学依据，促进临床应用。

关键词: 再灌注损伤, 脑缺血, 卒中, 线粒体通透性转换孔, 通督调神, 电针疗法, miR-124-3p, 穴，百会, 穴，风府, 穴，大椎

ZHANG Guoqing,TONG Tingting,WANG Ying, et al. Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury[J]. Chinese General Practice, 2023, 26(24): 3050-3060. DOI: 10.12114/j.issn.1007-9572.2023.0056.
张国庆,童婷婷,王颖等. "通督调神"电针预处理介导miR-124-3p/GSK-3β/Cyp-D信号通路对脑缺血再灌注损伤大鼠脑皮质线粒体通透性转换孔的影响及机制探讨[J]. 中国全科医学, 2023, 26(24): 3050-3060. DOI: 10.12114/j.issn.1007-9572.2023.0056.

Figures/Tables 12

References 41

[1]	HE Z, NING N Y, ZHOU Q X，et al. Mitochondria as a therapeutic target for ischemic stroke[J]. Free Radic Biol Med，2020,146:45-58. DOI：10.1016/j.freeradbiomed.2019.11.005.
[2]	LAPCHAK P A, ZHANG J H. The high cost of stroke and stroke cytoprotection research[J]. Transl Stroke Res，2017,8(4):307-317. DOI：10.1007/s12975-016-0518-y.
[3]	POWERS W J, RABINSTEIN A A, ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American heart association/American stroke association[J]. Stroke，2019,50(12):e344-418. DOI：10.1161/STR.0000000000000211.
[4]	GUO P P, JIN Z, WU H S，et al. Effects of irisin on the dysfunction of blood-brain barrier in rats after focal cerebral ischemia/reperfusion[J]. Brain Behav，2019,9(10):e01425. DOI：10.1002/brb3.1425.
[5]	TIAN W Q, ZHU M M, ZHOU Y D，et al. Electroacupuncture pretreatment alleviates cerebral ischemia-reperfusion injury by regulating mitophagy via mTOR-ULK1/FUNDC1 axis in rats[J]. J Stroke Cerebrovasc Dis，2022,31(1):106202. DOI：10.1016/j.jstrokecerebrovasdis.2021.106202.
[6]	LONG M, WANG Z G, ZHENG D，et al. Electroacupuncture pretreatment elicits neuroprotection against cerebral ischemia-reperfusion injury in rats associated with transient receptor potential vanilloid 1-mediated anti-oxidant stress and anti-inflammation[J]. Inflammation，2019,42(5):1777-1787. DOI：10.1007/s10753-019-01040-y.
[7]	HE Z, NING N Y, ZHOU Q X，et al. Mitochondria as a therapeutic target for ischemic stroke[J]. Free Radic Biol Med，2020,146:45-58. DOI：10.1016/j.freeradbiomed.2019.11.005.
[8]	LI S Q, ZHOU Y, GU X C，et al. NLRX1/FUNDC1/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury[J]. Cell Prolif，2021,54(3):e12986. DOI：10.1111/cpr.12986.
[9]	ANZELL A R, MAIZY R, PRZYKLENK K，et al. Mitochondrial quality control and disease：insights into ischemia-reperfusion injury[J]. Mol Neurobiol，2018,55(3):2547-2564. DOI：10.1007/s12035-017-0503-9.
[10]	HUANG J L, MANAENKO A, YE Z H，et al. Hypoxia therapy—a new hope for the treatment of mitochondrial dysfunctions[J]. Med Gas Res，2016,6(3):174-176. DOI：10.4103/2045-9912.191365.
[11]	REN Z L, WANG C D, WANG T，et al. Ganoderma lucidum extract ameliorates MPTP-induced Parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function，autophagy，and apoptosis[J]. Acta Pharmacol Sin，2019,40(4):441-450. DOI：10.1038/s41401-018-0077-8.
[12]	YANG H, LI R Z, ZHANG L，et al. p53-cyclophilin D mediates renal tubular cell apoptosis in ischemia-reperfusion-induced acute kidney injury[J]. Am J Physiol Renal Physiol，2019,317(5):F1311-1317. DOI：10.1152/ajprenal.00072.2019.
[13]	LIU X R, LI F, ZHAO S F，et al. MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke[J]. Stroke，2013,44(7):1973-1980. DOI：10.1161/STROKEAHA.111.000613.
[14]	MIAO W, YAN Y, BAO T H，et al. Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124[J]. Biomedecine Pharmacother，2020,126:109786. DOI：10.1016/j.biopha.2019.109786.
[15]	TANG S L, HUANG Q H, WU L G，et al. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis[J]. Eur Rev Med Pharmacol Sci，2018,22(20):6616-6624. DOI：10.26355/eurrev_201810_16136.
[16]	YANG K, CHEN Z X, GAO J J，et al. The key roles of GSK-3β in regulating mitochondrial activity[J]. Cell Physiol Biochem，2017,44(4):1445-1459. DOI：10.1159/000485580.
[17]	余曙光，徐斌. 实验针灸学[M]. 3版. 北京：人民卫生出版社，2021.
[18]	包新杰，赵浩，魏俊吉，等. 线栓法建立大鼠局灶性脑缺血模型的改进[J]. 中国脑血管病杂志，2011,8(5):248-252. DOI：10.3969/j.issn.1672-5921.2011.05.006.
[19]	LONGA E Z, WEINSTEIN P R, CARLSON S，et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke，1989,20(1):84-91. DOI：10.1161/01.str.20.1.84.
[20]	XIN J H, MA X X, CHEN W Y，et al. Regulation of blood-brain barrier permeability by Salvinorin A via alleviating endoplasmic reticulum stress in brain endothelial cell after ischemia stroke[J]. Neurochem Int，2021,149:105093. DOI：10.1016/j.neuint.2021.105093.
[21]	郑仕平，韩为，储浩然，等. 通督调神针灸预处理对脑缺血再灌注大鼠相关微小RNA调控机制的研究[J]. 针刺研究，2015,40(2):99-103. DOI：10.13702/j.1000-0607.2015.02.003.
[22]	彭静，陈曦. "补肾通督，醒脑益智"法电针治疗血管性痴呆80例[J]. 中国针灸，2022,42(6):623-624. DOI：10.13703/j.0255-2930.20210413-0005.
[23]	刘燕，王陈妮，兰崴，等. 通督调神针刺对脑缺血再灌注损伤大鼠神经功能及VEGF、NGF、MBP表达的影响[J]. 中国中医基础医学杂志，2022,28(2):218-223. DOI：10.19945/j.cnki.issn.1006-3250.2022.02.020.
[24]	谷诗浓，刘毓佳，王振杰，等. 基于细胞自噬探讨通督调神针法对缺血再灌注大鼠神经功能及Beclin-1蛋白表达的影响[J]. 针灸临床杂志，2020,36(10):64-68.
[25]	黄亚光，杨松柏，杜利鹏，等. 电针预处理通过调控皮层区自噬改善大鼠脑缺血再灌注损伤[J]. 针刺研究，2019,44(12):867-872. DOI：10.13702/j.1000-0607.190307.
[26]	ZHANG G F, YANG P, YIN Z，et al. Electroacupuncture preconditioning protects against focal cerebral ischemia/reperfusion injury via suppression of dynamin-related protein 1[J]. Neural Regen Res，2018,13(1):86-93. DOI：10.4103/1673-5374.224373.
[27]	JIN Z, GUO P P, LI X Y，et al. Neuroprotective effects of irisin against cerebral ischemia/reperfusion injury via Notch signaling pathway[J]. Biomedecine Pharmacother，2019,120:109452. DOI：10.1016/j.biopha.2019.109452.
[28]	BOCK F J, TAIT S W G. Mitochondria as multifaceted regulators of cell death[J]. Nat Rev Mol Cell Biol，2020,21(2):85-100. DOI：10.1038/s41580-019-0173-8.
[29]	BONORA M, GIORGI C, PINTON P. Molecular mechanisms and consequences of mitochondrial permeability transition[J]. Nat Rev Mol Cell Biol，2022,23(4):266-285. DOI：10.1038/s41580-021-00433-y.
[30]	MORCIANO G, NAUMOVA N, KOPROWSKI P，et al. The mitochondrial permeability transition pore：an evolving concept critical for cell life and death[J]. Biol Rev Camb Philos Soc，2021,96(6):2489-2521. DOI：10.1111/brv.12764.
[31]	LIU K, YAN L H, JIANG X J，et al. Acquired inhibition of microRNA-124 protects against spinal cord ischemia-reperfusion injury partially through a mitophagy-dependent pathway[J]. J Thorac Cardiovasc Surg，2017,154(5):1498-1508. DOI：10.1016/j.jtcvs.2017.05.046.
[32]	李杰，马跃文，康楠，等. 体外放散式冲击波促进脑梗死大鼠海马区神经干细胞增殖并抑制miR-124的表达[J]. 中国组织工程研究，2021,25(31):4981-4987.
[33]	TANG S L, HUANG Q H, WU L G，et al. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis[J]. Eur Rev Med Pharmacol Sci，2018,22(20):6616-6624. DOI：10.26355/eurrev_201810_16136.
[34]	WONG T C, FUNG J Y, PANG H H，et al. Analysis of survival benefits of living versus deceased donor liver transplant in high model for end-stage liver disease and hepatorenal syndrome[J]. Hepatology，2021,73(6):2441-2454. DOI：10.1002/hep.31584.
[35]	JUHASZOVA M, ZOROV D B, KIM S H，et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore[J]. J Clin Invest，2004,113(11):1535-1549. DOI：10.1172/JCI19906.
[36]	ZHOU L J, MO Y B, BU X，et al. Erinacine facilitates the opening of the mitochondrial permeability transition pore through the inhibition of the PI3K/Akt/GSK-3β signaling pathway in human hepatocellular carcinoma[J]. Cell Physiol Biochem，2018,50(3):851-867. DOI：10.1159/000494472.
[37]	PÉREZ M J, QUINTANILLA R A. Development or disease：duality of the mitochondrial permeability transition pore[J]. Dev Biol，2017,426(1):1-7. DOI：10.1016/j.ydbio.2017.04.018.
[38]	WANG H J, ZHU J, JIANG L P，et al. Mechanism of Heshouwuyin inhibiting the Cyt c/Apaf-1/Caspase-9/Caspase-3 pathway in spermatogenic cell apoptosis[J]. BMC Complement Med Ther，2020,20(1):180. DOI：10.1186/s12906-020-02904-9.
[39]	JIN Z, GUO P P, LI X Y，et al. Neuroprotective effects of irisin against cerebral ischemia/reperfusion injury via Notch signaling pathway[J]. Biomedecine Pharmacother，2019,120:109452. DOI：10.1016/j.biopha.2019.109452.
[40]	张利达，韩为，高志波，等. "通督调神"法针刺联合颈动脉内膜剥脱术治疗颈动脉狭窄：随机对照研究[J]. 中国针灸，2022,42(2):121-125. DOI：10.13703/j.0255-2930.20210202-k0007.
[41]	罗佛赐，韩为，张利达，等. 通督调神针刺联合西药对短暂性脑缺血发作合并高尿酸血症患者颈动脉斑块的影响[J]. 上海针灸杂志，2021,40(7):789-794. DOI：10.13460/j.issn.1005-0957.2021.07.0789.

基因名称	扩增长度（bp）	上游引物（5'→3'）	下游引物（5'→3'）
β-actin	150	CCCATCTATGAGGGTTACGC	TTTAATGTCACGCACGATTTC
U6	94	CTCGCTTCGGCAGCACA	AACGCTTCACGAATTTGCGT
Cyp-D	101	ATCCTTAGCAAGTGTCTCGG	CTGGTCAAGGAAAAAGGCAG
GSK-3β	113	ACTTTGGAAGTGCAAAGCAG	ACTAGACGTGTAATCGGTGG
Cyt-C	86	TAAGACTGGACCAAACCTCC	TGTTCTTGTTGGCATCTGTG
Caspase-3	138	ATGTCGATGCAGCTAACCTC	AACTGCTCCTTTTGCTGTGA
miR-124-3p	64	ACACTCCAGCTGGGTAAGGCACGCGGTG	TGGTGTCGTGGAGTCG
miR-124-3p-RT		CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGGCATT

基因名称	扩增长度（bp）	上游引物（5'→3'）	下游引物（5'→3'）
β-actin	150	CCCATCTATGAGGGTTACGC	TTTAATGTCACGCACGATTTC
U6	94	CTCGCTTCGGCAGCACA	AACGCTTCACGAATTTGCGT
Cyp-D	101	ATCCTTAGCAAGTGTCTCGG	CTGGTCAAGGAAAAAGGCAG
GSK-3β	113	ACTTTGGAAGTGCAAAGCAG	ACTAGACGTGTAATCGGTGG
Cyt-C	86	TAAGACTGGACCAAACCTCC	TGTTCTTGTTGGCATCTGTG
Caspase-3	138	ATGTCGATGCAGCTAACCTC	AACTGCTCCTTTTGCTGTGA
miR-124-3p	64	ACACTCCAGCTGGGTAAGGCACGCGGTG	TGGTGTCGTGGAGTCG
miR-124-3p-RT		CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGGCATT

组别	只数	mNSS评分〔M（P₂₅，P₇₅），分〕	只数	相对脑梗死体积（±s，% ）
假手术组	20	0（0，0）	5	0
模型组	20	10（10，11）^a	5	34.95±3.80^a
电针组	20	6（6，7）^b	5	22.37±3.73^b
抑制剂组	20	6（5，7）^b	5	17.88±1.90^b
电针+激动剂组	20	10（9，10）^c	5	30.85±1.56^c
F（H）值		86.638		135.041^e
P值		<0.001		<0.001

组别	只数	mNSS评分〔M（P₂₅，P₇₅），分〕	只数	相对脑梗死体积（±s，% ）
假手术组	20	0（0，0）	5	0
模型组	20	10（10，11）^a	5	34.95±3.80^a
电针组	20	6（6，7）^b	5	22.37±3.73^b
抑制剂组	20	6（5，7）^b	5	17.88±1.90^b
电针+激动剂组	20	10（9，10）^c	5	30.85±1.56^c
F（H）值		86.638		135.041^e
P值		<0.001		<0.001

组别	只数	AI（%）	GSK-3β	p-GSK-3β	Cyp-D
假手术组	5	15.68±2.07	0.59±0.02	0.61±0.03	0.14±0.01
模型组	5	60.14±2.70^a	0.60±0.04	0.16±0.02^a	0.61±0.04^a
电针组	5	37.14±1.91^b	0.59±0.02	0.37±0.04^b	0.37±0.02^b
抑制剂组	5	28.98±1.96^bc	0.59±0.01	0.50±0.03^bc	0.28±0.02^bc
电针+激动剂组	5	41.28±2.75^bc	0.60±0.05	0.27±0.03^bc	0.46±0.04^bc
F值		251.206	0.205	157.005	193.968
P值		<0.001	0.932	<0.001	<0.001

Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury

"通督调神"电针预处理介导miR-124-3p/GSK-3β/Cyp-D信号通路对脑缺血再灌注损伤大鼠脑皮质线粒体通透性转换孔的影响及机制探讨

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 12

References 41

Related Articles 15

Recommended Articles

Metrics

Comments

组别	只数	miR-124-3p	GSK-3β	Cyp-D	Cyt-C	Caspase-3
假手术组	6	1.00±0.05	1.02±0.03	0.91±0.14	0.97±0.08	0.98±0.05
模型组	6	1.94±0.10^a	0.48±0.11^a	2.32±0.11^a	2.78±0.04^a	1.92±0.11^a
电针组	6	1.32±0.05^b	0.79±0.08^b	1.88±0.24^b	2.09±0.14^b	1.38±0.03^b
抑制剂组	6	0.16±0.01^bc	0.94±0.05^bc	1.40±0.16^bc	1.59±0.05^bc	1.24±0.05^bc
电针+激动剂组	6	1.46±0.06^bc	0.68±0.05^c	2.06±0.08^b	2.42±0.05^bc	1.59±0.08^bc
F值		664.668	57.980	78.919	487.748	162.193
P值		<0.001	<0.001	<0.001	<0.001	<0.001

组别	只数	p-GSK-3β/ GSK-3β	Cyp-D	Cyt-C	Caspase-3
假手术组	6	0.95±0.18	0.25±0.06	0.08±0.05	0.10±0.02
模型组	6	0.37±0.13^a	0.95±0.12^a	0.82±0.10^a	0.79±0.14^a
电针组	6	0.62±0.13^b	0.51±0.09^b	0.43±0.12^b	0.46±0.13^bc
抑制剂组	6	0.73±0.10^b	0.36±0.03^bc	0.10±0.06^bc	0.31±0.08^b
电针+激动剂组	6	0.47±0.11^bc	0.75±0.11^bc	0.60±0.09^bc	0.62±0.09^bc
F值		17.343	65.481	80.363	41.303
P值		<0.001	<0.001	<0.001	<0.001

组别	只数	MPTP阳性细胞率（%）
假手术组	4	20.575±2.085
模型组	4	0.865±0.207^a
电针组	4	6.753±0.076^b
抑制剂组	4	16.350±0.493^bc
电针+激动剂组	4	2.690±0.338^bc
F值		313.385
P值		<0.001

[1]	BAI Haiwei, MI Xiaokun, LIU Qingrui, ZHU Lin, WANG Yingnan, LIU Junyan, HAN Ying. Predictive Value of Serum Uric Acid in Perioperative Acute Ischemic Stroke in Patients with Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(36): 4545-4551.
[2]	LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424.
[3]	QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289.
[4]	SU Kaiqi, LYU Zhuan, WU Mingli, LUO Meng, GAO Jing, NIE Chenchen, LIU Hao, FENG Xiaodong. Effect of Electroacupuncture on BDNF/TrkB/PI3K/Akt Pathway and Hippocampal Neuronal Protection in Rats with Learning and Memory Impairment after Ischemia Reperfusion [J]. Chinese General Practice, 2023, 26(33): 4187-4193.
[5]	YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212.
[6]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[7]	YANG Yuxuan, ZHANG Han, DU Juan, WANG Lingling, XIE Yulei, YIN Kaiming, ZHANG Bo. Value of an Dynamic Eye-tracking Task in Assessing Unilateral Spatial Neglect after Stroke [J]. Chinese General Practice, 2023, 26(32): 4020-4025.
[8]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[9]	XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840.
[10]	LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422.
[11]	CHEN Xi, LUO Jianyu, KUANG Zaoyuan, XU Qin. Effect of Paeonol on Improving Behavioral Dysfunction in a Mouse Model of Middle Cerebral Artery Occlusion [J]. Chinese General Practice, 2023, 26(27): 3441-3449.
[12]	ZHENG Siting, HE Chunyu, ZHOU Jun, KONG Ye, YANG Xinyao, ZHOU Haiying, WEI Xiaofei. Summary of Best Evidence for Self-Management of Patients with Motor Dysfunction after Stroke [J]. Chinese General Practice, 2023, 26(26): 3230-3237.
[13]	Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219.
[14]	WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296.
[15]	DU Yuying, WANG Cailing, CUI Senlin, LEI lei, WANG Yanping, SONG Xueqin, HAN Shuqin, ZHANG Yanmei, WANG Baolan, HUANG Haixia, CHEN Mi, YAN Huirong, LI Dong, ZHANG Jingjing, REN Yu. Analysis of Appropriate Technology Promotion for Stroke Rehabilitation in Southern Xinjiang [J]. Chinese General Practice, 2023, 26(25): 3178-3184.